BLIS Technologies Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 47

Employees

  • Stock Symbol
  • BLT

Stock Symbol

  • Share Price
  • $0.01
  • (As of Friday Closing)

BLIS Technologies General Information

Description

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.

Contact Information

Website
www.blis.co.nz
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Post Box 2208
  • South Dunedin
  • Dunedin, 9044
  • New Zealand
+64 03
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NZE
Corporate Office
  • Post Box 2208
  • South Dunedin
  • Dunedin, 9044
  • New Zealand
+64 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BLIS Technologies Stock Performance

As of 13-Nov-2026, BLIS Technologies’s stock price is $0.01. Its current market cap is $17.7M with 1.28B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $17.7M 1.28B 483K

BLIS Technologies Financials Summary

As of 31-Mar-2026, BLIS Technologies has a trailing 12-month revenue of $7.87M.

In Thousands,
USD
TTM 31-Mar-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 5,627 5,627 5,364 8,550
Revenue 7,865 7,865 6,840 6,386
EBITDA 582 582 626 518
Net Income 406 406 496 393
Total Assets 8,556 8,556 8,157 7,713
Total Debt 251 251 336 232
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BLIS Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BLIS Technologies‘s full profile, request access.

Request a free trial

BLIS Technologies Patents

BLIS Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025904966-A0 Treatment of pathogenic bacteria in non-human animals Pending 21-Oct-2025
EP-4424178-A1 Production of a probiotic composition Pending 03-Mar-2023
US-12714731-B2 Production of a probiotic composition Active 03-Mar-2023
US-20240293479-A1 Production of a probiotic composition Active 03-Mar-2023
US-20260306558-A1 Production of a probiotic composition Pending 03-Mar-2023 A61K35/741
To view BLIS Technologies’s complete patent history, request access »

BLIS Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BLIS Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BLIS Technologies‘s full profile, request access.

Request a free trial

BLIS Technologies ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view BLIS Technologies’s complete esg history, request access »

BLIS Technologies FAQs

  • When was BLIS Technologies founded?

    BLIS Technologies was founded in 2000.

  • Where is BLIS Technologies headquartered?

    BLIS Technologies is headquartered in Dunedin, New Zealand.

  • What is the size of BLIS Technologies?

    BLIS Technologies has 47 total employees.

  • What industry is BLIS Technologies in?

    BLIS Technologies’s primary industry is Biotechnology.

  • Is BLIS Technologies a private or public company?

    BLIS Technologies is a Public company.

  • What is BLIS Technologies’s stock symbol?

    The ticker symbol for BLIS Technologies is BLT.

  • What is the current stock price of BLIS Technologies?

    As of 13-Nov-2026 the stock price of BLIS Technologies is $0.01.

  • What is the current market cap of BLIS Technologies?

    The current market capitalization of BLIS Technologies is $17.7M.

  • What is BLIS Technologies’s current revenue?

    The trailing twelve month revenue for BLIS Technologies is $7.87M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process